Course Provider
Learning Objectives
Upon completion of this activity, participants should be better able to differentiate available and emerging therapies for advanced renal cell carcinoma (RCC) based on mechanism of action, indication, placement in treatment, safety, and efficacy
Upon completion of this activity, participants should be better able to apply current evidence to individualize treatment decision-making and sequencing of therapies for patients with advanced/metastatic RCC
Upon completion of this activity, participants should be better able to develop evidence-based strategies for monitoring and mitigating adverse events of novel therapies for treatment of advanced/metastatic RCC
Upon completion of this activity, participants should be better able to employ interprofessional strategies for quality patient-centered care, including shared decision-making, to optimize outcomes for patients with RCC